D009396DisordersC04.557.435.595C04.588.945.947.535.585C04.700.635C12.758.820.750.585C12.777.419.473.585C13.351.937.820.535.585C13.351.968.419.473.585C16.320.700.6421162920.798384Wilms TumorFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonGeneticsPediatricsRadiation OncologyMD AndersonVICKI DHUFFVICKI D HUFF8525HUFF, VICKI DProfessorNAJATDAW BITARNAJAT DAW BITAR9691DAW BITAR, NAJATProfessorARNOLD DELA CRUZPAULINOARNOLD DELA CRUZ PAULINO9923PAULINO, ARNOLD DELA CRUZProfessor74Professortrue1ProfessorProfessor7.262310.00340446116research area of0.9813880.0071737201subject area forDepartment of PediatricsPediatrics-OncologyBaylor College of MedicineMURALICHINTAGUMPALAMURALI CHINTAGUMPALA0.000000000000000.000000000000003240CHINTAGUMPALA, MURALIProfessortrue1ProfessorProfessor37788149Connolly GK, Harris RD, Shumate C, Rednam SP, Canfield MA, Plon SE, Nguyen J, Schraw JM, Lupo PJCancerPediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population-based assessment in seven million children. Cancer. 2024 02 01; 130(3):467-475.Cancer2023-10-03T00:00:002023Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population-based assessment in seven million children.37848532Perotti D, Williams RD, Wegert J, Brzezinski J, Maschietto M, Ciceri S, Gisselsson D, Gadd S, Walz AL, Furtwaengler R, Drost J, Al-Saadi R, Evageliou N, Gooskens SL, Hong AL, Murphy AJ, Ortiz MV, O'Sullivan MJ, Mullen EA, van den Heuvel-Eibrink MM, Fernandez CV, Graf N, Grundy PE, Geller JI, Dome JS, Perlman EJ, Gessler M, Huff V, Pritchard-Jones KNature reviews. UrologyHallmark discoveries in the biology of Wilms tumour. Nat Rev Urol. 2024 03; 21(3):158-180.Nat Rev Urol2023-10-17T00:00:002023Hallmark discoveries in the biology of Wilms tumour.37902955Evageliou N, Renfro LA, Geller J, Perlman E, Kalapurakal J, Paulino A, Dix D, Eklund MJ, Murphy AJ, Romao RLP, Ehrlich PF, Varela CR, Vallance K, Fernandez CV, Dome JS, Mullen EACancerPrognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532. Cancer. 2024 03 01; 130(5):792-802.Cancer2023-10-30T00:00:002023Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.38036539Su X, Lu X, Bazai SK, Dainese L, Verschuur A, Dumont B, Mouawad R, Xu L, Cheng W, Yan F, Irtan S, Lindner V, Paillard C, Le Bouc Y, Coulomb A, Malouf GGNature communicationsDelineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors. Nat Commun. 2023 Nov 30; 14(1):7884.Nat Commun2023-11-30T00:00:002023Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors.38110397Murphy AJ, Cheng C, Williams J, Shaw TI, Pinto EM, Dieseldorff-Jones K, Brzezinski J, Renfro LA, Tornwall B, Huff V, Hong AL, Mullen EA, Crompton B, Dome JS, Fernandez CV, Geller JI, Ehrlich PF, Mulder H, Oak N, Maciezsek J, Jablonowski CM, Fleming AM, Pichavaram P, Morton CL, Easton J, Nichols KE, Clay MR, Santiago T, Zhang J, Yang J, Zambetti GP, Wang Z, Davidoff AM, Chen XNature communicationsGenetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q. Nat Commun. 2023 Dec 18; 14(1):8006.Nat Commun2023-12-18T00:00:002023Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorRAJKUMARVENKATRAMANIRAJKUMAR VENKATRAMANI7908VENKATRAMANI, RAJKUMAR0000-0002-4785-106XProfessor